IGF Antibodies

Santa Cruz Biotechnology features a diverse variety of IGF Antibodies for the study of insulin-like growth factors. IGF Antibodies are compatible with multiple research applications, including western blotting (WB), immunoprecipitation (IP), immunofluorescence (IF), immunohistochemistry with paraffin-embedded sections (IHCP), flow cytometry (FCM), and enzyme-linked immunosorbent assay (ELISA). Insulin-like growth factors play a crucial role in cell growth, development, and metabolism, influencing processes such as cell proliferation and differentiation. IGF proteins are essential for normal physiological functions and have been implicated in various diseases, including cancer and metabolic disorders. Understanding the signaling pathways and mechanisms of IGF can provide insights into therapeutic targets and disease progression. IGF research continues to reveal new connections between cellular signaling networks and disease states. Investigating IGF pathways helps illuminate potential treatment strategies for various medical conditions. The molecular interactions of IGF with other signaling molecules present opportunities for therapeutic intervention. Santa Cruz Biotechnology monoclonal antibodies support researchers worldwide in advancing scientific understanding of IGF biology and its impact on human health.